Over the past decade, testing for mutations to the genes known as BRCA1 and BRCA2 has become a highly-regarded tool in the fight against breast cancer and ovarian cancer. And it's given people with the genes - both those with cancer and those who don't have it - information they can use to detect cancer early, prevent a recurrence or keep from getting it at all.